ROIV financial statements
The full income statement, balance sheet, and cash-flow statement for Roivant Sciences Ltd. (ROIV), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
| Revenue | 8.26M YoY-71.6% | 29.1M YoY-11.2% | 32.7M YoY+3.8% | 31.5M YoY-43.0% | 55.3M YoY+132.3% | |
1.29B YoY+13.2% | 1.14B YoY+29.3% | 884M YoY-5.8% | 938M YoY-33.3% | 1.41B YoY+28.5% | ||
| Operating income | -515M YoY+48.7% | -1.00B YoY-122.3% | 4.50B YoY+595.9% | -907M YoY+32.9% | -1.35B YoY-26.2% | |
| Interest expense | — | — | 34.8M YoY+24.3% | 28.0M YoY+297.2% | 7.04M YoY+150.7% | |
| Interest & investment income | 178M YoY-31.1% | 258M YoY+76.5% | 146M | — | — | |
| Other non-operating income | 4.01M YoY+137.4% | -10.7M YoY+20.9% | -13.6M YoY-2690.5% | -486K YoY-115.0% | 3.24M YoY+137.2% | |
| Equity-method income | — | — | — | — | 0.00 YoY+100.0% | |
| Pre-tax income | -265M YoY+61.2% | -682M YoY-114.9% | 4.57B YoY+616.1% | -885M YoY+4.2% | -924M YoY-2.8% | |
| Income tax | 133M YoY+176.8% | 48.2M YoY+124.0% | 21.5M YoY+426.8% | 4.08M YoY+1006.2% | 369K YoY-78.1% | |
-300M YoY-74.3% | -172M YoY-104.0% | 4.35B YoY+531.0% | -1.01B YoY-19.4% | -845M YoY-4.5% | ||
-$0.54 YoY-125.0% | -$0.24 YoY-104.6% | $5.23 YoY+468.3% | -$1.42 YoY-12.7% | -$1.26 | ||
| Balance Sheet | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
5.17B YoY+3.3% | 5.00B YoY-25.7% | 6.73B YoY+274.3% | 1.80B YoY-16.2% | 2.15B YoY-1.9% | ||
5.71B YoY+5.0% | 5.44B YoY-24.7% | 7.22B YoY+202.2% | 2.39B YoY-7.6% | 2.59B YoY-0.2% | ||
281M YoY+88.2% | 149M YoY-44.0% | 267M YoY-2.1% | 272M YoY+47.8% | 184M YoY-15.8% | ||
416M YoY+66.7% | 250M YoY-67.7% | 774M YoY-1.0% | 782M YoY+49.3% | 524M YoY-0.8% | ||
4.53B YoY-3.4% | 4.69B YoY-21.5% | 5.97B YoY+415.5% | 1.16B YoY-30.1% | 1.66B YoY-7.8% | ||
| Cash Flow | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
-750M YoY+10.6% | -839M YoY-9.7% | -765M YoY+9.3% | -843M YoY-24.4% | -678M YoY-22.7% | ||
-682M YoY+61.4% | -1.77B YoY-133.9% | 5.20B YoY+11854.6% | -44.3M YoY-114.6% | 303M YoY+1056.7% | ||
134M YoY+111.0% | -1.22B YoY-390.9% | 419M YoY-16.0% | 499M YoY+62.8% | 307M YoY-32.8% | ||
| FX effect on cash | — | — | 616K YoY-90.2% | 6.28M | 0.00 | |
| Net change in cash | -1.29B YoY+66.2% | -3.82B YoY-178.7% | 4.86B YoY+1372.1% | -382M YoY-464.6% | -67.6M | |
| Interest paid | 0.00 YoY-100.0% | 5.96M YoY-41.9% | 10.3M YoY+93.6% | 5.30M YoY-4.2% | 5.54M YoY+174.4% | |
| Income taxes paid | 48.4M YoY-21.9% | 61.9M YoY+401.1% | 12.4M YoY+140.9% | 5.13M YoY+459.8% | 916K YoY-77.5% | |
| Valuation Ratios | as ofMar 31 ’26 | as ofMar 31 ’25 | as ofMar 31 ’24 | as ofMar 31 ’23 | as ofMar 31 ’22 | |
| Market cap | 19.9B YoY+190.5% | 6.86B YoY-19.2% | 8.49B YoY+50.1% | 5.66B YoY+63.5% | 3.46B YoY-45.7% | |
| P/E | — | — | 1.9× | — | — | |
| P/S | 2412.1× YoY+921.7% | 236.1× YoY+6.9% | 220.8× YoY+23.0% | 179.5× YoY+186.6% | 62.6× YoY-76.6% | |
| P/B | 4.4× YoY+200.7% | 1.5× YoY+4.9% | 1.4× YoY-71.5% | 4.9× YoY+134.0% | 2.1× YoY-41.1% | |
— | — | 52.6% | — | — | ||
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ROIV's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ROIV filings on SEC EDGAR → Not investment advice.
